肺动脉
缺氧(环境)
MMP2型
下调和上调
PI3K/AKT/mTOR通路
肺动脉高压
基因敲除
细胞生长
细胞生物学
化学
细胞
癌症研究
间充质干细胞
生物
细胞凋亡
医学
信号转导
内科学
生物化学
氧气
基因
有机化学
作者
Shasha Ning,Xinyue Guo,Yanan Zhu,Chenghui Li,Ruixue Li,Mengsun Yu,Wei Luo,Dezhang Lu,Yupeng Yin
出处
期刊:
[Cold Spring Harbor Laboratory]
日期:2022-08-08
标识
DOI:10.1101/2022.08.08.503173
摘要
Abstract Pulmonary hypertension (PH) is a kind of fatal disease. There are no existing drugs that could reverse the diseas. NF-E2-related factor 2 (NRF2) is one of the most important moleculars in the range of cell protection. We examined the expression of NRF2 in PH models and explored the role of NRF2 in regulating abnormal phenotypes in pulmonary artery cells. We determined the expression level of NRF2 in lung tissues of PH model decreased significantly. We found that NRF2 was reduced in rat pulmonary artery endothelial cells (rPAEC) under hypoxia, while it was overexpressed in rat pulmonary artery smooth muscle cells (rPASMC) under hypoxia. Next, the results showed that knockdown NRF2 in rPAEC promoted endothelial-mesenchymal transformation and upregulated reactive oxygen species level. After the rPASMC was treated with siRNA or activator, we found that NRF2 could promote cell proliferation by regulating PDGFR/ERK1/2 and mTOR/P70S6K pathways, and accelerate cell migration by affecting MMP2/3/7. Therefore, the study suggests that the combination of NRF2 activators should be considered to eliminate the promoting effect of NRF2 activators on proliferation and migration of rPASMC. Summary statement Hypoxia regulates NRF2 in PAECs and PASMCs differently. We found that NRF2 could promote cell proliferation by regulating PDGFR/ERK1/2 and mTOR/P70S6K pathways, and accelerate cell migration by affecting MMP2/3/7.
科研通智能强力驱动
Strongly Powered by AbleSci AI